
About Maximon Pharma
Maximon Pharma is a Healthcare company based in Delhi (India) founded in 2018. It supplies and exports pharmaceutical products, medicines, and health supplements globally. It operates on a B2B and B2C model. The company has 8 employees. Its Indian entity Maximon Pharma Private Limited reported revenue of βΉ1.55 Cr. Maximon Pharma offers products and services including AntiFlux D, Calcigem D, Durasol D3, Neurorize OD Plus, and Diclopentin. Its focus areas include Pharmaceuticals, Medicines, General Wellbeing and Health Supplements. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
Maximon Pharma Private Limited, based in New Delhi, India, operates as a supplier and exporter of various medicines and health supplements. The company focuses on providing high-quality products at affordable prices to domestic and international markets, including areas like musculoskeletal and female healthcare. They emphasize reliability and aim to improve patient quality of life through cost-effective solutions. Backed by an experienced team, they handle distribution and exports efficiently.
- Headquarters Delhi, India
- Employees 8
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website maximonwellness.com
- Legal Name Maximon Pharma Private Limited
- Date of Incorporation 12 Jun, 2018
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹1.55 Cr
FY 2025 · +30% YoY
- Net Profit₹18.4 Lakh
FY 2025 · 12% margin
- EBITDA₹12.1 Lakh
FY 2025 · 8% margin
- Employee Count8
Associated legal entities of Maximon Pharma
Maximon Pharma operates through Maximon Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Maximon Pharma Private Limited CIN U74900DL2018PTC335210 | Active | 12 Jun 2018 | New Delhi, Delhi | ₹1.6 Cr | 8 | 6 | View details |
Products & Services of Maximon Pharma
Maximon Pharma offers a comprehensive portfolio of products and services, including AntiFlux D, Calcigem D, Durasol D3, Neurorize OD Plus, and Diclopentin.
Medicine aimed at treating acid-related conditions effectively.
Supplement for bone health and calcium support in daily use.
Vitamin D supplement to aid immune and bone functions regularly.
Medication for nerve health and overall wellbeing support.
Pain relief medicine for musculoskeletal issues and discomfort.
Supplement promoting general health and quality of life improvements.
Board of directors of Maximon Pharma Private Limited (Maximon Pharma)
Maximon Pharma Private Limited is the primary company behind Maximon Pharma. The board of Maximon Pharma Private Limited currently have 6 directors; the longest-serving is Harshavardhan Karunakar Hegde, appointed in 2018. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Harshavardhan Karunakar Hegde DIN 03050173 | Director | 12 Jun 2018 | 8 yrs 5 mo | Maximon Pharma Private Limited |
| Akshay Kumar Saxena DIN 08155730 | Director | 12 Jun 2018 | 8 yrs 5 mo | Maximon Pharma Private Limited |
| Rakesh Mattoo DIN 06587788 | Director | 12 Jun 2018 | 8 yrs 5 mo | Maximon Pharma Private Limited |
| Sarita Kapur DIN 08848507 | Director | 01 Aug 2021 | 5 yrs 3 mo | Maximon Pharma Private Limited |
| Anjali Harshavardhan Hegde DIN 01683723 | Director | 01 Aug 2021 | 5 yrs 3 mo | Maximon Pharma Private Limited |
| Arundhati Hegde DIN 09010739 | Director | 01 Aug 2021 | 5 yrs 3 mo | Maximon Pharma Private Limited |
Financials of Maximon Pharma
Figures of Maximon Pharma Private Limited, the primary company behind Maximon Pharma, for FY 2025. Revenue was ₹1.55 Cr (+30% year on year). Net profit was ₹18.4 Lakh (12% margin). EBITDA was ₹12.1 Lakh (8% margin). Revenue has grown at a compounded annual rate of -11% over three years and +18% over five years.
- ₹1.55 CrRevenue · FY 2025 · +30% YoY
- ₹18.4 LakhNet profit · 12% margin
- ₹12.1 LakhEBITDA · 8% margin
- ₹1 LakhPaid-up capital
- 8Employees (provident fund records)
- -11%Revenue CAGR, 3 years
- +18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Maximon Pharma Private Limited are on its company page.
Detailed financial statements for Maximon Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Maximon Pharma
Maximon Pharma has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of Maximon Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Maximon Pharma
Complete news archive for Maximon Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maximon Pharma
Maximon Pharma was founded in 2018.
Maximon Pharma is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Maximon Pharma has 8 employees.
The primary company behind Maximon Pharma, Maximon Pharma Private Limited, reported revenue of βΉ1.55 Cr for FY 2025, up 30% year on year.
Maximon Pharma Private Limited, based in New Delhi, India, operates as a supplier and exporter of various medicines and health supplements. The company focuses on providing high-quality products at affordable prices to domestic and international markets, including areas like musculoskeletal and female healthcare. They emphasize reliability and aim to improve patient quality of life through cost-effective solutions. Backed by an experienced team, they handle distribution and exports efficiently.
Maximon Pharma's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
Maximon Pharma offers AntiFlux D, Calcigem D, Durasol D3, Neurorize OD Plus, and 2 more products and services.
Maximon Pharma operates through Maximon Pharma Private Limited.
The legal entities of Maximon Pharma currently have 6 directors, including Sarita Kapur, Harshavardhan Karunakar Hegde, Akshay Kumar Saxena and others.
